Jeffrey M. Peters
Department of Veterinary and Biomedical Sciences
The Pennsylvania State University
Jeffrey M. Peters has not added Biography.
If you are Jeffrey M. Peters and would like to personalize this page please email our Author Liaison for assistance.
Hepatic regeneration in peroxisome proliferator-activated receptor alpha-null mice after partial hepatectomy.
Hepatology research : the official journal of the Japan Society of Hepatology Jan, 2002 | Pubmed ID: 11804834
Induction of CYP3A expression by dehydroepiandrosterone: involvement of the pregnane X receptor.
Drug metabolism and disposition: the biological fate of chemicals May, 2002 | Pubmed ID: 11950789
Targeted disruption of peroxisomal proliferator-activated receptor beta (delta) results in distinct gender differences in mouse brain phospholipid and esterified FA levels.
Lipids May, 2002 | Pubmed ID: 12056592
Effects of conjugated linoleic acid (CLA) on immune responses, body composition and stearoyl-CoA desaturase.
Canadian journal of applied physiology = Revue canadienne de physiologie appliquee Dec, 2002 | Pubmed ID: 12501000
Bezafibrate is a dual ligand for PPARalpha and PPARbeta: studies using null mice.
Biochimica et biophysica acta Jun, 2003 | Pubmed ID: 12782154
Comprehensive gene expression analysis of peroxisome proliferator-treated immortalized hepatocytes: identification of peroxisome proliferator-activated receptor alpha-dependent growth regulatory genes.
Cancer research Sep, 2003 | Pubmed ID: 14522898
PPARalpha agonist-induced rodent tumors: modes of action and human relevance.
Critical reviews in toxicology , 2003 | Pubmed ID: 14727734
Expression of base excision DNA repair genes is a sensitive biomarker for in vivo detection of chemical-induced chronic oxidative stress: identification of the molecular source of radicals responsible for DNA damage by peroxisome proliferators.
Cancer research Feb, 2004 | Pubmed ID: 14871837
Peroxisome proliferator-activated receptor beta/delta regulates very low density lipoprotein production and catabolism in mice on a Western diet.
The Journal of biological chemistry May, 2004 | Pubmed ID: 15001574
Peroxisome proliferator-activated receptor beta (delta)-dependent regulation of ubiquitin C expression contributes to attenuation of skin carcinogenesis.
The Journal of biological chemistry May, 2004 | Pubmed ID: 15033975
Peroxisome proliferator-activated receptor-delta attenuates colon carcinogenesis.
Nature medicine May, 2004 | Pubmed ID: 15048110
PPARgamma influences susceptibility to DMBA-induced mammary, ovarian and skin carcinogenesis.
Carcinogenesis Sep, 2004 | Pubmed ID: 15073042
Reduced adiposity and liver steatosis by stearoyl-CoA desaturase deficiency are independent of peroxisome proliferator-activated receptor-alpha.
The Journal of biological chemistry Aug, 2004 | Pubmed ID: 15180999
PPARbeta/delta potentiates PPARgamma-stimulated adipocyte differentiation.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology Sep, 2004 | Pubmed ID: 15247146
Activation of mouse and human peroxisome proliferator-activated receptors (PPARs) by phthalate monoesters.
Toxicological sciences : an official journal of the Society of Toxicology Nov, 2004 | Pubmed ID: 15310864
The United States-Japan workshop on: The role of nuclear receptors in carcinogenesis.
Molecular carcinogenesis Oct, 2004 | Pubmed ID: 15378646
Peroxisome proliferator-activated receptor alpha protects against alcohol-induced liver damage.
Hepatology (Baltimore, Md.) Oct, 2004 | Pubmed ID: 15382117
Role of peroxisome proliferator-activated receptor-alpha (PPARalpha) in bezafibrate-induced hepatocarcinogenesis and cholestasis.
Carcinogenesis Jan, 2005 | Pubmed ID: 15447978
PPARdelta status and Apc-mediated tumourigenesis in the mouse intestine.
Oncogene Nov, 2004 | Pubmed ID: 15480419
Regulation of human apoA-I by gemfibrozil and fenofibrate through selective peroxisome proliferator-activated receptor alpha modulation.
Arteriosclerosis, thrombosis, and vascular biology Mar, 2005 | Pubmed ID: 15618549
Peroxisome proliferator-activated receptor-beta/delta inhibits epidermal cell proliferation by down-regulation of kinase activity.
The Journal of biological chemistry Mar, 2005 | Pubmed ID: 15632134
Differences in cell proliferation in rodent and human hepatic derived cell lines exposed to ciprofibrate.
Cancer letters May, 2005 | Pubmed ID: 15863271
Peroxisome proliferator-activated receptor-alpha and liver cancer: where do we stand?
Journal of molecular medicine (Berlin, Germany) Oct, 2005 | Pubmed ID: 15976920
Protective effects of a peroxisome proliferator-activated receptor-beta/delta agonist in experimental autoimmune encephalomyelitis.
Journal of neuroimmunology Nov, 2005 | Pubmed ID: 16098614
The role of peroxisome proliferator-activated receptor-beta/delta in epithelial cell growth and differentiation.
Cellular signalling Jan, 2006 | Pubmed ID: 16109478
Evidence that ligand binding is a key determinant of Ah receptor-mediated transcriptional activity.
Archives of biochemistry and biophysics Oct, 2005 | Pubmed ID: 16137638
The aryl hydrocarbon receptor directly regulates expression of the potent mitogen epiregulin.
Toxicological sciences : an official journal of the Society of Toxicology Jan, 2006 | Pubmed ID: 16192470
The toxicology of ligands for peroxisome proliferator-activated receptors (PPAR).
Toxicological sciences : an official journal of the Society of Toxicology Apr, 2006 | Pubmed ID: 16322072
Alterations in skin and stratified epithelia by constitutively activated PPARalpha.
The Journal of investigative dermatology Feb, 2006 | Pubmed ID: 16374467
Inhibition of chemically induced skin carcinogenesis by sulindac is independent of peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta).
Carcinogenesis May, 2006 | Pubmed ID: 16418176
PPARdelta regulates glucose metabolism and insulin sensitivity.
Proceedings of the National Academy of Sciences of the United States of America Feb, 2006 | Pubmed ID: 16492734
Ligand activation of peroxisome proliferator-activated receptor beta inhibits colon carcinogenesis.
Cancer research Apr, 2006 | Pubmed ID: 16618765
PPARdelta status and mismatch repair mediated neoplasia in the mouse intestine.
BMC cancer May, 2006 | Pubmed ID: 16672050
Regulation of hepatic fatty acid elongase and desaturase expression in diabetes and obesity.
Journal of lipid research Sep, 2006 | Pubmed ID: 16790840
Modes of action and species-specific effects of di-(2-ethylhexyl)phthalate in the liver.
Critical reviews in toxicology May, 2006 | Pubmed ID: 16954067
Sustained formation of alpha-(4-pyridyl-1-oxide)-N-tert-butylnitrone radical adducts in mouse liver by peroxisome proliferators is dependent upon peroxisome proliferator-activated receptor-alpha, but not NADPH oxidase.
Free radical biology & medicine Feb, 2007 | Pubmed ID: 17210446
Ligand activation of peroxisome proliferator-activated receptor-beta/delta(PPARbeta/delta) inhibits cell growth of human N/TERT-1 keratinocytes.
Cellular signalling Jun, 2007 | Pubmed ID: 17254750
PPARalpha and effects of TCE.
Environmental health perspectives Jan, 2007 | Pubmed ID: 17366801
The oxidative stress mediator 4-hydroxynonenal is an intracellular agonist of the nuclear receptor peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta).
Free radical biology & medicine Apr, 2007 | Pubmed ID: 17382197
PPARbeta/delta protects against experimental colitis through a ligand-independent mechanism.
Digestive diseases and sciences Nov, 2007 | Pubmed ID: 17404849
Deregulation of tumor angiogenesis and blockade of tumor growth in PPARbeta-deficient mice.
The EMBO journal Aug, 2007 | Pubmed ID: 17641685
Transcriptional network governing the angiogenic switch in human pancreatic cancer.
Proceedings of the National Academy of Sciences of the United States of America Jul, 2007 | Pubmed ID: 17652168
Growth of transgenic RAF-induced lung adenomas is increased in mice with a disrupted PPARbeta/delta gene.
International journal of oncology Sep, 2007 | Pubmed ID: 17671688
Peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta) ligands do not potentiate growth of human cancer cell lines.
Carcinogenesis Dec, 2007 | Pubmed ID: 17693664
COX-2 suppresses tissue factor expression via endocannabinoid-directed PPARdelta activation.
The Journal of experimental medicine Sep, 2007 | Pubmed ID: 17724132
Ligand activation of peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta) and inhibition of cyclooxygenase 2 (COX2) attenuate colon carcinogenesis through independent signaling mechanisms.
Carcinogenesis Jan, 2008 | Pubmed ID: 17893232
Induction of nuclear translocation of constitutive androstane receptor by peroxisome proliferator-activated receptor alpha synthetic ligands in mouse liver.
The Journal of biological chemistry Dec, 2007 | Pubmed ID: 17962186
Peroxisome proliferator-activated receptor-beta/delta protects against chemically induced liver toxicity in mice.
Hepatology (Baltimore, Md.) Jan, 2008 | Pubmed ID: 18038451
Peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta) ligands inhibit growth of UACC903 and MCF7 human cancer cell lines.
Toxicology Jan, 2008 | Pubmed ID: 18054822
Quantitative expression patterns of peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta) protein in mice.
Biochemical and biophysical research communications Jul, 2008 | Pubmed ID: 18442472
A Role for PPARbeta/delta in Tumor Stroma and Tumorigenesis.
PPAR research , 2008 | Pubmed ID: 18497874
Role of peroxisome-proliferator-activated receptor beta/delta (PPARbeta/delta) in gastrointestinal tract function and disease.
Clinical science (London, England : 1979) Aug, 2008 | Pubmed ID: 18616431
Ligand activation of peroxisome proliferator-activated receptor beta/delta (PPARbeta/delta) attenuates carbon tetrachloride hepatotoxicity by downregulating proinflammatory gene expression.
Toxicological sciences : an official journal of the Society of Toxicology Oct, 2008 | Pubmed ID: 18622026
Ligand activation of peroxisome proliferator-activated receptor-beta/delta inhibits cell proliferation in human HaCaT keratinocytes.
Molecular pharmacology Nov, 2008 | Pubmed ID: 18687807
Peroxisome proliferator-activated receptor-delta agonist enhances vasculogenesis by regulating endothelial progenitor cells through genomic and nongenomic activations of the phosphatidylinositol 3-kinase/Akt pathway.
Circulation Sep, 2008 | Pubmed ID: 18711014
Nrf2- and PPAR alpha-mediated regulation of hepatic Mrp transporters after exposure to perfluorooctanoic acid and perfluorodecanoic acid.
Toxicological sciences : an official journal of the Society of Toxicology Dec, 2008 | Pubmed ID: 18757529
Ligand activation of peroxisome proliferator-activated receptor beta/delta (PPAR beta/delta) inhibits chemically induced skin tumorigenesis.
Carcinogenesis Dec, 2008 | Pubmed ID: 18799709
Effect of ligand activation of peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta) in human lung cancer cell lines.
Toxicology Dec, 2008 | Pubmed ID: 18950674
PPARdelta is pro-tumorigenic in a mouse model of COX-2-induced mammary cancer.
Prostaglandins & other lipid mediators Apr, 2009 | Pubmed ID: 19101649
Regulation of peroxisome proliferator-activated receptor-alpha by MDM2.
Toxicological sciences : an official journal of the Society of Toxicology Mar, 2009 | Pubmed ID: 19103650
Regulation of peroxisome proliferator-activated receptors by e6-associated protein.
PPAR research , 2008 | Pubmed ID: 19107217
Differential hepatic effects of perfluorobutyrate mediated by mouse and human PPAR-alpha.
Toxicological sciences : an official journal of the Society of Toxicology Jul, 2009 | Pubmed ID: 19359353
Regulation of peroxisome proliferator-activated receptor-beta/delta by the APC/beta-CATENIN pathway and nonsteroidal antiinflammatory drugs.
Molecular carcinogenesis Oct, 2009 | Pubmed ID: 19415698
Sorting out the functional role(s) of peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta) in cell proliferation and cancer.
Biochimica et biophysica acta Dec, 2009 | Pubmed ID: 19505534
Ligand activation of peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta) inhibits cell growth in a mouse mammary gland cancer cell line.
Cancer letters Feb, 2010 | Pubmed ID: 19660859
Ligand activation of peroxisome proliferator-activated receptor-beta/delta and inhibition of cyclooxygenase-2 enhances inhibition of skin tumorigenesis.
Toxicological sciences : an official journal of the Society of Toxicology Jan, 2010 | Pubmed ID: 19748995
Regulation of oligodendrocyte progenitor cell maturation by PPARδ: effects on bone morphogenetic proteins.
ASN neuro Jan, 2010 | Pubmed ID: 20001953
A natural propenoic acid derivative activates peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta).
Life sciences Mar, 2010 | Pubmed ID: 20153754
Cellular and pharmacological selectivity of the peroxisome proliferator-activated receptor-beta/delta antagonist GSK3787.
Molecular pharmacology Sep, 2010 | Pubmed ID: 20516370
Synthesis of isosteric selenium analog of the PPARbeta/delta agonist GW501516 and comparison of biological activity.
Bioorganic & medicinal chemistry letters Jul, 2010 | Pubmed ID: 20542425
Effect of prenatal peroxisome proliferator-activated receptor alpha (PPARalpha) agonism on postnatal development.
Toxicology Sep, 2010 | Pubmed ID: 20637823
Xenobiotic metabolism, disposition, and regulation by receptors: from biochemical phenomenon to predictors of major toxicities.
Toxicological sciences : an official journal of the Society of Toxicology Mar, 2011 | Pubmed ID: 21059794
Chemoprevention of chemically induced skin tumorigenesis by ligand activation of peroxisome proliferator-activated receptor-beta/delta and inhibition of cyclooxygenase 2.
Molecular cancer therapeutics Dec, 2010 | Pubmed ID: 21159610
PPARβ/δ activation induces enteroendocrine L cell GLP-1 production.
Gastroenterology May, 2011 | Pubmed ID: 21300064
Functional characterization of peroxisome proliferator-activated receptor-β/δ expression in colon cancer.
Molecular carcinogenesis Nov, 2011 | Pubmed ID: 21400612
Stable over-expression of PPARβ/δ and PPARγ to examine receptor signaling in human HaCaT keratinocytes.
Cellular signalling Dec, 2011 | Pubmed ID: 21843636
PPAR action in insulin resistance unraveled by metabolomics: potential clinical implications.
Genome medicine Aug, 2011 | Pubmed ID: 21861850
Why toxic equivalency factors are not suitable for perfluoroalkyl chemicals.
Chemical research in toxicology Oct, 2011 | Pubmed ID: 21913657
Immunomodulatory action of dietary fish oil and targeted deletion of intestinal epithelial cell PPARδ in inflammation-induced colon carcinogenesis.
American journal of physiology. Gastrointestinal and liver physiology Jan, 2012 | Pubmed ID: 21940900
NTP-CERHR expert panel report on the developmental toxicity of soy infant formula.
Birth defects research. Part B, Developmental and reproductive toxicology Oct, 2011 | Pubmed ID: 21948615
Dissecting the role of peroxisome proliferator-activated receptor-β/δ (PPARβ/δ) in colon, breast, and lung carcinogenesis.
Cancer metastasis reviews Dec, 2011 | Pubmed ID: 22037942
The role of peroxisome proliferator-activated receptors in carcinogenesis and chemoprevention.
Nature reviews. Cancer Mar, 2012 | Pubmed ID: 22318237
Peroxisome proliferator-activated receptor β/δ cross talks with E2F and attenuates mitosis in HRAS-expressing cells.
Molecular and cellular biology Jun, 2012 | Pubmed ID: 22473992
Modulation of gastrointestinal inflammation and colorectal tumorigenesis by peroxisome proliferator-activated receptor-β/δ (PPARβ/δ).
Drug discovery today. Disease mechanisms , 2011 | Pubmed ID: 22611424
A species difference in the peroxisome proliferator-activated receptor α-dependent response to the developmental effects of perfluorooctanoic acid.
Toxicological sciences : an official journal of the Society of Toxicology Feb, 2013 | Pubmed ID: 23143925
Analysis of the peroxisome proliferator-activated receptor-β/δ (PPARβ/δ) cistrome reveals novel co-regulatory role of ATF4.
BMC genomics , 2012 | Pubmed ID: 23176727
Metabolomics: an essential tool to understand the function of peroxisome proliferator-activated receptor alpha.
Toxicologic pathology Feb, 2013 | Pubmed ID: 23197196
Cholestasis induces reversible accumulation of periplakin in mouse liver.
BMC gastroenterology Jul, 2013 | Pubmed ID: 23849208
PPARβ/δ modulates ethanol-induced hepatic effects by decreasing pyridoxal kinase activity.
Toxicology Sep, 2013 | Pubmed ID: 23851158
Mode of action framework analysis for receptor-mediated toxicity: The peroxisome proliferator-activated receptor alpha (PPARα) as a case study.
Critical reviews in toxicology Jan, 2014 | Pubmed ID: 24180432
Aryl hydrocarbon receptor antagonism attenuates growth factor expression, proliferation, and migration in fibroblast-like synoviocytes from patients with rheumatoid arthritis.
The Journal of pharmacology and experimental therapeutics Feb, 2014 | Pubmed ID: 24309559
Targeting estrogen receptor-β for the prevention of nonmelanoma skin cancer.
Cancer prevention research (Philadelphia, Pa.) Feb, 2014 | Pubmed ID: 24464730
Activation of peroxisome proliferator-activated receptor-β/δ (PPAR-β/δ) inhibits human breast cancer cell line tumorigenicity.
Molecular cancer therapeutics Apr, 2014 | Pubmed ID: 24464939
Modulation of aryl hydrocarbon receptor (AHR)-dependent signaling by peroxisome proliferator-activated receptor β/δ (PPARβ/δ) in keratinocytes.
Carcinogenesis Jul, 2014 | Pubmed ID: 24639079
The nuclear receptor peroxisome proliferator-activated receptor-β/δ (PPARβ/δ) promotes oncogene-induced cellular senescence through repression of endoplasmic reticulum stress.
The Journal of biological chemistry Jul, 2014 | Pubmed ID: 24898257
Comparative in vivo and in vitro analysis of possible estrogenic effects of perfluorooctanoic acid.
Toxicology Dec, 2014 | Pubmed ID: 25456267
M-CSF from Cancer Cells Induces Fatty Acid Synthase and PPARβ/δ Activation in Tumor Myeloid Cells, Leading to Tumor Progression.
Cell reports Mar, 2015 | Pubmed ID: 25753425
Targeting Peroxisome Proliferator-Activated Receptor-β/δ (PPARβ/δ) for Cancer Chemoprevention.
Current pharmacology reports , 2015 | Pubmed ID: 26000234
Peroxisome Proliferator-activated Receptor-D (PPARD) Coordinates Mouse Spermatogenesis by Modulating Extracellular Signal-regulated Kinase (ERK)-dependent Signaling.
The Journal of biological chemistry Sep, 2015 | Pubmed ID: 26242735
Inhibition of testicular embryonal carcinoma cell tumorigenicity by peroxisome proliferator-activated receptor-β/δ- and retinoic acid receptor-dependent mechanisms.
Oncotarget Nov, 2015 | Pubmed ID: 26431381
Establishing the Role of PPARβ/δ in Carcinogenesis.
Trends in endocrinology and metabolism: TEM Nov, 2015 | Pubmed ID: 26490384
The Ron Receptor Tyrosine Kinase Regulates Macrophage Heterogeneity and Plays a Protective Role in Diet-Induced Obesity, Atherosclerosis, and Hepatosteatosis.
Journal of immunology (Baltimore, Md. : 1950) Jul, 2016 | Pubmed ID: 27233965
Editor's Highlight: Perfluorooctane Sulfonate-Choline Ion Pair Formation: A Potential Mechanism Modulating Hepatic Steatosis and Oxidative Stress in Mice.
Toxicological sciences : an official journal of the Society of Toxicology Sep, 2016 | Pubmed ID: 27413108
Ligand activation of peroxisome proliferator-activated receptor-β/δ suppresses liver tumorigenesis in hepatitis B transgenic mice.
Toxicology Jul, 2016 | Pubmed ID: 27427494
PPARβ/δ selectively regulates phenotypic features of age-related macular degeneration.
Aging Sep, 2016 | Pubmed ID: 27622388
Regulation of Cytochrome P450 2B10 (CYP2B10) Expression in Liver by Peroxisome Proliferator-activated Receptor-β/δ Modulation of SP1 Promoter Occupancy.
The Journal of biological chemistry Nov, 2016 | Pubmed ID: 27765815
Omics Approaches To Probe Microbiota and Drug Metabolism Interactions.
Chemical research in toxicology Dec, 2016 | Pubmed ID: 27782392
Peroxisome proliferator-activated receptor-β/δ modulates mast cell phenotype.
Immunology Apr, 2017 | Pubmed ID: 27935639
Peroxisome proliferator-activated receptor-β/δ inhibits human neuroblastoma cell tumorigenesis by inducing p53- and SOX2-mediated cell differentiation.
Molecular carcinogenesis Dec, 2016 | Pubmed ID: 27996177
ABOUT JoVE
Copyright © 2024 MyJoVE Corporation. All rights reserved